Wolfe co-chairs international panel to develop treatment recommendations for myasthenia gravisPosted: August 10, 2016
Gil I. Wolfe, MD, Irvin and Rosemary Smith Professor and Chair of the UB Department of Neurology, along with his colleague from Duke University Medical Center, Donald Sanders, MD, has co-chaired the first-ever international panel of myasthenia gravis (MG) experts that developed consensus-based treatment recommendations for the disease. A variety of topics were covered including symptomatic and immunosuppressive therapy, plasma exchange and intravenous immunoglobulin, MG crisis, thymectomy, juvenile MG, and MG in pregnancy. The consensus statement was published in July 2016 in the journal Neurology (see Intl MG Rx statement 7.16). The panel’s work was supported by a grant from the MG Foundation of America.